Las Vegas Review-Journal

In California, pot caught in haze of regs

- By Michael R. Blood The Associated Press

LOS ANGELES — Ready or not, California kicks off recreation­al marijuana sales on Jan. 1. And, mostly, it’s not.

Los Angeles and San Francisco are among many cities still struggling to fashion local rules for pot shops and growers. Without the regulation­s, there could be limited options in many places for consumers eager to ring in the new year with a legal pot purchase.

“The bulk of folks probably are not going to be ready Jan. 1,” con

MARIJUANA

ceded Cara Martinson of the California State Associatio­n of Counties.

In general, California will treat cannabis like alcohol, allowing people 21 and older to legally possess up to an ounce and grow six marijuana plants at home.

Come January, the newly legalized recreation­al sales will be merged with the state’s two-decade-old medical marijuana market, which is also coming under much stronger regulation.

But big gaps loom in the system intended to move cannabis from the field to distributi­on centers, then to testing labs and eventually retail shops.

The state plans to issue only temporary licenses starting in January, and it has yet to release its plan to govern the estimated $7 billion marketplac­e, the nation’s largest legal pot economy.

If businesses aren’t licensed and operating in the legal market, government­s aren’t collecting their slice of revenue from sales. The state alone estimates it could see as much as $1 billion roll in within several years.

Operators have complained about what they see as potential conflicts in various laws and rules, or seemingly contradict­ory plans.

The state expects businesses that receive licenses will only work with others that hold them. But that has alarmed operators who wonder what will happen if their supplier, for instance, decides not to join the new legal market.

Others say it’s not clear what could happen in cities that don’t enact pot laws, which they warn could open a loophole for businesses to set up shop. Some communitie­s have banned recreation­al sales.

Most banks continue to refuse to do business with marijuana operators because pot remains illegal under federal law, and there are also problems obtaining insurance.

With recreation­al legalizati­on fast-approachin­g, “we don’t have enough of anything,” lamented Hezekiah Allen, executive director of the California Growers Associatio­n, a marijuana industry group.

The route to legalizati­on began last year when voters approved Propositio­n 64, which opened the way for recreation­al pot sales to adults in the nation’s most populous state.

Unlike the state, cities and counties face no deadline to act. But the concern is that confusion and a patchwork of local rules could discourage operators from entering the legal economy, feeding a black market that could undercut the legitimate one.

Local regulation is a foundation block of the emerging pot economy: A grower or retailer needs a local permit first, which is a steppingst­one to obtaining a state license to operate.

But those rules remain in limbo in many places.

San Jose, the state’s third-largest city, has a temporary ban on sales other than medical pot, but officials this week proposed hearings to take another look at how to regulate the local industry.

Kern County, home to nearly 900,000 people, has banned the sale of marijuana even as California legalizes it. Supervisor­s said they see it as a danger to citizens and also voted to phase out more than two dozen medical marijuana dispensari­es.

San Diego is among the cities ready to get the recreation­al market going.

Phil Rath, executive director of the United Medical Marijuana Coalition, a San Diego trade group, said years of disorder in the medical market led to increased black market business. That provided a ready example of how not to manage recreation­al sales.

San Diego moved promptly, setting up a system that will allow recreation­al sales at dispensari­es permitted under the medical system, once they qualify for a state license. Interactiv­e News Media

— A pill that relieves joint pain and stiffness in 7 days without side effects has been used safely in Germany for 53 years. It is now available in the United States.

This pill contains an active ingredient that not only relieves pain quickly, but also works to rebuild damaged cartilage between bones for greater range of motion.

It can cut your pain relief costs up to 82% less than using pain relief drugs and pain relief cream and heat products.

An improved version of this pill is now being offered in the United States under the brand name Flexjointp­lus.

Flexjointp­lus relieves joint pain, back pain, neck pain, carpal tunnel, sprains, strains, sports injuries, and more. With daily use, users can expect to feel 24-hour relief.

The active ingredient in Flexjointp­lus comes from a natural source. It is both safe and healthy. In 53 years of recorded medical use, there have been no reported harmful side effects.

“Relief in pain and stiffness is felt in as quickly as 7 days,” said Roger Lewis, Chief Researcher for Flexjointp­lus.

“And with regular use, you can expect even more reduction in the following 30-60 days,” added Lewis. the

July 2014.

The study involved patients with a variety of joint pain conditions associated with osteoarthr­itis. They were not instructed to change their daily routines. They were only told to take Flexjointp­lus’ active ingredient every day.

The results incredible.

Taking Flexjointp­lus’ active ingredient just once daily significan­tly reduced both joint pain and stiffness compared to placebo at 7, 30, and 60 days.

In fact, many patients experience­d greater than 50% reduction in pain and stiffness at 60 days.

They also enjoyed an improvemen­t in stiffness when first getting out of the bed in the morning, and an improvemen­t in pain when doing light household chores.

With these studies medical doctors and researcher­s have now proven Flexjointp­lus to be a clinically effective treatment for reducing pain and stiffness associated with joint and connective tissue disorders, especially osteoarthr­itis.

The findings are impressive, no doubt, but results will vary.

But with results like these it’s easy to see why thousands of callers are jamming the phone lines trying to get their hands on Flexjointp­lus. in were ligaments,” explains Dr. Sarah Brewer, renowned Author and graduate from Cambridge University.

There also have been no adverse side effects reported with the use of NEM®.

This is a bonus for arthritis sufferers who have been taking prescripti­on and over the counter medication­s that can cause severe gastric irritation over time, like NSAIDS.

This seems to be another reason why Flexjointp­lus’ release has triggered such a frenzy of sales.

“Based on my 20 years of experience treating people with osteoarthr­itis, Flexjointp­lus receives my highest recommenda­tion to any person suffering from joint pain and stiffness,” said Dr. David Vallance, Rheumatolo­gist from Ann Arbor, MI.

“One of my patients taking Flexjointp­lus has reported a significan­t decrease in pain when going up or down stairs, sitting with legs bent for an extended period of time, and even getting up from a seated position,” said Dr. Richard Gibson, chiropract­or from Windsor, ON.

“I use Flexjointp­lus everyday for my stiff and aching joints. I also have my wife and daughter taking it regularly as well,” said Dr. Oozer, G.P. from Lasalle, CA.

 ??  ??

Newspapers in English

Newspapers from United States